Investing.com··GurufocusCatalyst Pharmaceuticals Trades at Deep Discount Despite Strong Cash Generation
Catalyst Pharmaceuticals trades at 20-33% discount to peers with 7.5% FCF yield; 2026 Hetero litigation is binary catalyst determining if shares reach $28-32 or collapse to $16-20.
CPRXpatent cliffvaluation discount